Our mission is to transform cancer care with enhanced detection, classification, and monitoring for improved treatment success
Detect cancer early when it is treatable
A novel genome-wide sequencing technique by the founders of Methylomics, to construct genome-wide DNA methylation profiles of normal and diseased tissue types
A proprietary Multiplex qPCR assay for the detection of cervical AND all other anogenital cancer with a superior sensitivity and specificity
An atlas for improved diagnosis, classification and monitoring of cancer from blood
